The MarketWatch News Department was not involved in the creation of this content. Faster Clinical Translation and Commercialization of Therapies Derived From iPSC Technology GERMANTOWN, MARYLAND / ...
Using a circuit-based system, scientists determined the ideal transcription factor levels to promote the successful reprogramming of fibroblasts into induced pluripotent stem cells. Scientists ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback